Headache News and Research

Latest Headache News and Research

Science backs old fashioned belief in the healing powers of honey

Research by Canadian scientists lends support to the old fashioned belief in the healing powers of honey.

25 Sep 2008

Woman dies after being scratched by a wild rat

As a rule leptospirosis victims experience severe headaches and flu-like symptoms but the severe form which is Weil's disease, causes jaundice and liver damage, and can be fatal - but it usually only affects 10% of leptospirosis victims.

15 Sep 2008

FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV

The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.

14 Sep 2008

FDA approves Gamunex for chronic inflammatory demyelinating polyneuropathy

The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.

14 Sep 2008

New marker for raised intracranial pressure

Magnetic resonance imaging (MRI) measurements of the thickness of the optic nerve sheath are a good marker for raised intracranial pressure (ICP).

10 Sep 2008

Migraine with aura may be linked to increased risk of stroke and heart attacks

Doctors need to pay special attention to people with migraine with aura as they could be at increased risk of stroke or heart attack, a London conference heard Friday 5 September.

7 Sep 2008

Trial demonstrates safety and efficacy of neurally acting anti-migraine agent for treatment of acute migraine

CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.

7 Sep 2008

Vimpat (lacosamide) approved in Europe

UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.

3 Sep 2008

Reuters examines how laws, conservative attitudes are hampering efforts to fight HIV/AIDS in Malaysia

Reuters on Thursday examined how some laws and widespread conservative attitudes are hindering efforts to fight the spread of HIV/AIDS in Malaysia, a predominantly Muslim country where high-risk groups are driven "deeper underground" because of the situation.

3 Aug 2008

Desmopressin for bed-wetting linked to convulsions in children

Australian authorities have issued a warning regarding a drug sometimes used to treat primary nocturnal enuresis (bed-wetting) in children.

3 Aug 2008

Sleep apnea associated with increased risk of death

Sleep-disordered breathing (also known as sleep apnea) is associated with an increased risk of death, according to new results from the Wisconsin Sleep Cohort, an 18-year observational study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

3 Aug 2008

Good news for the treatment of Alzheimer's disease

Research presented at an international conference on Alzheimer's disease in Chicago offers hope for the treatment of the devastating disease.

29 Jul 2008

Raltegravir drug combo works against highly resistant strain of HIV

A study involving an international team of scientists has discovered that a new drug when combined with other anti-HIV medications, is particularly effective against a highly resistant strain of the HIV virus.

24 Jul 2008

Patent for Aciphex ruled valid and enforceable

PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today that the U.S. Federal Circuit Court of Appeals affirmed the judgments of the United States District Court for the Southern District of New York that the patent for Aciphex (rabeprazole sodium 20 mg tablets) is valid and enforceable.

21 Jul 2008

New clues to the biological basis of migraines

Fifteen percent to 20 percent of people worldwide suffer from migraines - excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder.

1 Jul 2008

Hand-held magnetic pulse device relieves migraines

The therapy known as noninvasive transcranial magnetic stimulation, or TMS, sparks a magnetic pulse which, when held against a person's head, creates an electric current among the nerves cells of the brain.

30 Jun 2008

Novel electronic device "zaps" away migraine pain

A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center.

26 Jun 2008

Women, Latinos face higher brain aneurysm risk

A type of stroke that can strike at any age, and kills one-third of its victims, appears to be more common in women and Mexican-Americans than in non-Hispanic white men, according to a new study from the University of Michigan Stroke Program.

15 Jun 2008

Hope on the horizon for migraine sufferers

A generation of anti-migraine drugs with fewer side effects than existing treatments could be available to sufferers within three years.

11 Jun 2008

St. John's wort not effective for treating ADHD

Children and teens with attention-deficit/hyperactivity disorder (ADHD) who were treated with the herb St. John's wort did not have any greater improvement in ADHD symptoms compared to those who received placebo, according to a study in the June 11 issue of JAMA, the Journal of the American Medical Association.

11 Jun 2008